Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
Recruiting
Observational Study
Chronic Liver Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- Association HGE CHU Bordeaux Sud · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this retrospective and prospective study is to evaluate the 20-year prognosis value of non-invasive methods for the diagnosis of chronic liver disease for predicting survival and complications of cirrhosis.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* chronic hepatitis C
* chronic hepatitis B
* alcohol liver disease
* non alcoholic liver disease
Exclusion Criteria:
* ascitis
Contacts